EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    4.1.3.3 | Carcinoma, Hepatocellular |
4289103 |
[On the activity of neuraminic acid aldolase and neuraminidase in the cells of ascite and solid forms of hepatoma 22 in mice] |
ongoing research
unassigned |
4
0 |
| 4.1.3.3 | Foot-and-Mouth Disease |
21320350 |
Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli. |
ongoing research
therapeutic application
unassigned |
1
1
0 |
| 4.1.3.3 | Influenza, Human |
15858666 |
Synthesis of screening substrates for the directed evolution of sialic acid aldolase: towards tailored enzymes for the preparation of influenza A sialidase inhibitor analogues. |
therapeutic application
unassigned |
3
0 |
| 4.1.3.3 | Nephrosis |
13994626 |
[Neuraminic acid aldolase activity in rat kidneys in experimental nephrosis.] |
ongoing research
unassigned |
2
0 |
| 4.1.3.3 | Pasteurella Infections |
15731025 |
Sialic Acid metabolism and systemic pasteurellosis. |
unassigned |
0 |
| 4.1.3.3 | Sialic Acid Storage Disease |
30568043 |
Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function. |
causal interaction
unassigned |
2
0 |
| 4.1.3.3 | Teratocarcinoma |
4065222 |
Sialic acid lyase in differentiating murine teratocarcinoma cells. |
causal interaction
unassigned |
1
0 |
| 4.1.3.3 | Tuberculosis |
18054225 |
Inhibiting dihydrodipicolinate synthase across species: towards specificity for pathogens? |
therapeutic application
unassigned |
1
0 |
